pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
411
stories
May 30, 26
#ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts say
endpoints
May 29, 26
Bristol Myers unveils data for one of its next-gen blood cancer drugs
biopharma dive
May 29, 26
Kenya court suspends U.S. plan for Ebola quarantine facility for Americans
stat
May 29, 26
Agios ends development of tebapivat in low-risk MDS following subpar results
endpoints
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive
May 29, 26
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
stat
May 28, 26
AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchase
endpoints
May 22, 26
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
fda press
May 19, 26
BioMarin drug acquired in buyout misses goal in rare disease study
biopharma dive
May 19, 26
A migraine drugmaker heads to the public markets through reverse merger
biopharma dive
May 19, 26
Relay drug shows early promise against rare blood vessel diseases
biopharma dive
May 18, 26
FDA approves AstraZeneca’s new kind of hypertension drug
biopharma dive
May 18, 26
Regeneron immunotherapy combo comes up short in melanoma trial
biopharma dive
May 18, 26
Texas is opening up a detransition clinic
stat
May 18, 26
FDA approves AstraZeneca’s baxdrostat for certain patients with hypertension
endpoints
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 15, 26
A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recorded
stat
May 15, 26
PSA screening for prostate cancer reduces disease-specific deaths, new review shows
stat
May 14, 26
STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more
stat
May 14, 26
BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
endpoints
May 14, 26
Opinion: Using AI in addiction medicine could be particularly risky
stat
May 13, 26
Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practice
onclive
May 13, 26
FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
onclive
May 13, 26
FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
onclive
May 13, 26
Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AML
onclive
May 13, 26
Future Directions in Metastatic Castration-Resistant Prostate Cancer
onclive
May 13, 26
Personalized Treatment Decision-Making in Metastatic Castration-Resistant Prostate Cancer
onclive
May 13, 26
Future Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Cancer
onclive
May 13, 26
Safety and Toxicity Management in Metastatic Castration-Resistant Prostate Cancer
onclive
May 13, 26
Combination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Cancer
onclive
← prev
page 10 of 14
next →
